Table 6.

Complications for patients ≤30 y/o, 30 to 60 y/o, and ≥60 y/o

	≤30 y/o (n = 114)	30 to 60 y/o (n = 184)	≥60 y/o (n = 37)	p
Any	18 (15.8 %)	36 (19.5 %)	6 (16.2 %)	0.84
Pulmonary	14 (12.3 %)	22 (12.0 %)	3 (8.1 %)	0.46
Pneumonia	8 (7.0 %)	20 (10.9 %)	3 (8.1 %)	0.86
PE	4 (3.5 %)	4 (2.2 %)	0 (0.0 %)	0.045
ARF	0 (0.0 %)	2 (1.1 %)	1 (2.7 %)	0.32
ARDS	4 (3.5 %)	1 (0.5 %)	0 (0.0 %)	0.045
MOF	0 (0.0 %)	1 (0.5 %)	1 (2.7 %)	0.32
DVT	2 (1.8 %)	4 (2.2 %)	0 (0.0 %)	0.16
Infection	3 (2.6 %)	6 (3.3 %)	0 (0.0 %)	0.083
Sepsis	1 (0.9 %)	5 (2.7 %)	2 (5.4 %)	0.25
Death	2 (1.8 %)	2 (1.1 %)	1 (2.7 %)	0.75

p values are shown for the youngest versus the oldest patients. All p values for the middle age group versus the youngest group were nonsignificant (p > 0.05)

Pulmonary pulmonary complications include pneumonia, ARDS, and PE; ARDS adult respiratory distress syndrome; PE pulmonary embolism; ARF acute renal failure; MOF multiple organ failure; DVT deep venous thrombosis